About Lupus Together

Millions of people worldwide suffer from lupus—a disease for which there is no known cause, few medicines, and no cure.

Finally now, after decades of little action, things are happening. The community is seeing unprecedented interest from biotechnology and pharmaceutical companies that translates into dozens of companies interested in lupus and even more trials for lupus patients. As few as seven or eight years ago, there were just two to three trials in progress. Today there are over 150.

In recent years, more and more pharmaceutical and biotech companies have developed new lupus treatments and are conducting clinical trials. That’s why it is important to be informed about the clinical trial process and carefully weigh the pros and cons of participating in one.

Finding a safe and effective medicine for lupus is our best hope for stopping the destruction of this disease.

What is the goal of this program?

To get as many people enrolled in clinical trials for lupus as possible, so that the lupus community can finally get some answers on prevention, treatments, and a cure.

Who are we trying to reach?

All people with lupus in America, including women, children, and men.

Who sponsors the Initiative?

The Lupus Research Alliance sponsors LupusTrials.org to provide information about clinical trials and allow people to explore available studies in their area.

If you are looking for a clinical trial in your area, ask your doctor and/or search for one with the tools provided on the Find a Clinical Trial page.

Who We Are

People with lupus.
Investigators. 
Rheumatologists and other physicians. 
Advocates. 
Public health officials. 
Families. 
Nurses. 
Drug developers.
The Lupus Research Alliance.
Lupus organizations nationwide.

Together, we can aim to change how sick lupus makes you. Let's try.

“There’s little question that the outlook for lupus patients is terrific. But patients have to get involved. They have to do their part. So get involved. Ask your doctor what is happening in the development process for new therapies.”

–Richard Furie, MD